ASTRAZENECA PHARMA at All Time High; BSE HEALTHCARE Index Up 0.2%
December 17, 2019 09:48 AM

ASTRAZENECA PHARMA share price has hit an all-time high at Rs 2,927 (up 1.6%).

Meanwhile, the BSE HEALTHCARE Index is at 13,427 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE Index today are ASTRAZENECA PHARMA (up 1.6%) and SANOFI INDIA (up 0.5%).

SUVEN LIFESCIENCES and FDC LTD. (down 0.1%) are among the top losers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 1,404 to Rs 2,927, registering a gain of Rs 1,523 (up 107.9%).

The BSE HEALTHCARE has moved down from 13,790 to 13,427, loss of 363 points (down 2.8%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ASTRAZENECA PHARMA (up 107.9%), ABBOTT INDIA (up 75.3%) and PFIZER (up 56.2%).

What About the Benchmark Indices?

The BSE Sensex is at 41,151 (up 0.5%). The top gainers among the BSE Sensex stocks today are VEDANTA LTD (up 1.9%), MARUTI SUZUKI (up 1.6%) and TATA MOTORS DVR (up 1.4%). Other gainers include YES BANK (up 1.4%) and TATA MOTORS (up 1.3%). The most traded stocks in the BSE Sensex are YES BANK and ITC.

In the meantime, NSE Nifty is at 12,113 (up 0.5%). The top gainers in the NSE Nifty include VEDANTA LTD (up 1.8%), ZEE ENTERTAINMENT (up 1.4%) and INFOSYS (up 1.4%). Other gainers include MARUTI SUZUKI (up 1.4%) and TATA STEEL (up 1.4%).

Over the last 12 months, the BSE Sensex has moved up from 36,270 to 41,151, registering a gain of 4,881 points (up 13.4%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit down at Rs 215 million for the quarter ended June 2019, compared to a loss of Rs 291 million a year ago. Net Sales declined 4.9% to Rs 2.0 billion during the period as against Rs 2.2 billion in April-June 2018.

For the year ended March 2018, ASTRAZENECA PHARMA reported 29.2% increase in net profit to Rs 259.0 million compared to net profit of Rs 200.0 million during FY17.

Revenue of the company grew 4.3% to Rs 6 billion during FY18.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 104.9x.